Benzinga | May 10, 2021 08:31AM EDT

Cellectar Biosciences Q1 EPS $(0.13) Up From $(0.42) YoY

Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.13) per share. This is a 69.05 percent increase over losses of $(0.42) per share from the same period last year.